Zobrazeno 1 - 10
of 27
pro vyhledávání: '"H S, Mueller"'
Autor:
E. Bohner, C. Fischer, C. Gehlen, H. S. Müller, K. Osterminski, J. Ožbolt, P. Schießl, S. von Greve-Dierfeld, DAfStb
Die in der Schriftenreihe des Deutschen Ausschusses für Stahlbeton (DAfStb) mit den Heft-Nummern 601 und 602 veröffentlichten Beiträge fassen die Ergebnisse der DFG-Forschergruppe 537 Modellierung des Schadensfortschritts bei Korrosion von Stahl i
Autor:
M. Fenchel, A. Gardei, M. Krause, C. Maierhofer, F. Mielentz, B. Milman, H. S. Müller, M. Röllig, H. Wiggenhauser, J. Wöstmann, DAfStb
Das Ziel des Forschungsvorhabens bestand in der Entwicklung eines Untersuchungskonzepts zur sicheren Ortung und Erfassung von Gefügestörungen in einseitig zugänglichen Betonplatten durch den kombinierten Einsatz verschiedener zerstörungsfreier Pr
Autor:
J R, Kizer, C P, Cannon, C H, McCabe, H S, Mueller, M J, Schweiger, V G, Davis, R, Perritt, E M, Antman
Publikováno v:
American heart journal. 137(1)
Although studies have documented that randomized, controlled trials (RCTs) have a measurable influence on clinical practice, investigators have uncovered important deficiencies in the application of RCT findings to the management of acute myocardial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57573908123d9dd0b3e8fcaf322d85df
https://pubmed.ncbi.nlm.nih.gov/9878930
https://pubmed.ncbi.nlm.nih.gov/9878930
Autor:
C P, Cannon, C M, Gibson, C H, McCabe, A A, Adgey, M J, Schweiger, R F, Sequeira, G, Grollier, R P, Giugliano, M, Frey, H S, Mueller, R M, Steingart, W D, Weaver, F, Van de Werf, E, Braunwald
Publikováno v:
Circulation. 98(25)
Bolus thrombolytic therapy is a simplified means of administering thrombolysis that facilitates rapid time to treatment. TNK-tissue plasminogen activator (TNK-tPA) is a highly fibrin-specific single-bolus thrombolytic agent.In TIMI 10B, 886 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5975431e1ed268906d5bcbd6496d914b
https://pubmed.ncbi.nlm.nih.gov/9860780
https://pubmed.ncbi.nlm.nih.gov/9860780
Autor:
H S, Mueller, K, Chatterjee, K B, Davis, M A, Fifer, C, Franklin, M A, Greenberg, A J, Labovitz, P K, Shah, K J, Tuman, M H, Weil, W S, Weintraub
Publikováno v:
Journal of the American College of Cardiology. 32(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8e949376515374f6fdcfdb8588456c2
https://pubmed.ncbi.nlm.nih.gov/9741535
https://pubmed.ncbi.nlm.nih.gov/9741535
Autor:
C P, Cannon, C H, McCabe, S, Borzak, T D, Henry, M D, Tischler, H S, Mueller, R, Feldman, S T, Palmeri, K, Ault, S A, Hamilton, J M, Rothman, W F, Novotny, E, Braunwald
Publikováno v:
Circulation. 97(4)
Inhibitors of the platelet glycoprotein IIb/IIIa receptor given intravenously have been shown to be effective in reducing ischemic complications after coronary angioplasty and in unstable angina, making this a promising new class of agents for the tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc20df188fea89f0b14e00ed00ba7343
https://pubmed.ncbi.nlm.nih.gov/9468202
https://pubmed.ncbi.nlm.nih.gov/9468202
Publikováno v:
Journal of the American College of Cardiology. 26(4)
This study sought to assess the independent contribution of nonfatal reinfarction to the risk of subsequent death in patients with acute myocardial infarction undergoing thrombolytic therapy.A composite of "unsatisfactory outcomes" as an end point ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e035a6689f28a0a3e77b23fb88b18825
https://pubmed.ncbi.nlm.nih.gov/7560615
https://pubmed.ncbi.nlm.nih.gov/7560615
Autor:
J L, Anderson, L C, Becker, S G, Sorensen, L A, Karagounis, K F, Browne, P K, Shah, D C, Morris, D J, Fintel, H S, Mueller, A M, Ross
Publikováno v:
Journal of the American College of Cardiology. 20(4)
This double-blind, randomized, multicenter trial was designed to compare the effects of treatment with anistreplase (APSAC) and alteplase (rt-PA) on convalescent left ventricular function, morbidity and coronary artery patency at 1 day in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::900633a80f2cc9ac6d7dd7c86e959faa
https://pubmed.ncbi.nlm.nih.gov/1527286
https://pubmed.ncbi.nlm.nih.gov/1527286
Publikováno v:
Circulation research. 68(1)
Treatment of normal platelet-rich plasma with a physiological amount of insulin (100 microunits/ml, optimum concentration) for 3 hours at 23 degrees C stimulated the binding of prostaglandin E1 by more than twofold (3,940 +/- 250 sites/10(8) platelet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4081355148086807274a7bd9d6f67b3
https://pubmed.ncbi.nlm.nih.gov/1845854
https://pubmed.ncbi.nlm.nih.gov/1845854
Publikováno v:
Journal of the American College of Cardiology. 16(7)
In the conservative strategy arm of phase II of the Thrombolysis in Myocardial Infarction (TIMI) trial, 1,461 patients were treated with intravenous recombinant tissue-type plasminogen activator (rt-PA). Coronary angiography, with angioplasty if feas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4aa9c2f71f289b217145cc1a3fd03b7b
https://pubmed.ncbi.nlm.nih.gov/2123902
https://pubmed.ncbi.nlm.nih.gov/2123902